The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faure, M.
Right arrow Articles by Long, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faure, M.
Right arrow Articles by Long, E. O.
The Journal of Immunology, 2002, 168: 6208-6214.
Copyright © 2002 by The American Association of Immunologists

KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential

Mathias Faure and Eric O. Long1

Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852

KIR2DL4 (CD158d) is an unusual member of the killer cell Ig-like receptor family expressed in all NK cells and some T cells. KIR2DL4 activates the cytotoxicity of NK cells, despite the presence of an immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic tail. The role of this ITIM on the activating function of KIR2DL4, and whether it can provide inhibitory signals, is not known. Mutated forms of KIR2DL4 were engineered that lacked either the tyrosine in the ITIM or an arginine-tyrosine motif in the transmembrane region that is required for the activation signal. The activity of the mutated KIR2DL4 molecules was tested in a redirected lysis assay. The ITIM was not necessary for activation of lysis by KIR2DL4. The activation signal of KIR2DL4 was sensitive to inhibition by another ITIM-containing receptor. The activation-deficient mutant of KIR2DL4 inhibited the signal delivered by the activating receptor CD16. In pull-down experiments with GST fusion proteins, the tyrosine-phosphorylated cytoplasmic tail of KIR2DL4 bound the Src homology 2-containing phosphatases 1 and 2, as did the tail of the inhibitory receptor KIR2DL1. Therefore, KIR2DL4 has inhibitory potential in addition to its activating function.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Shahjahan Miah, T. L. Hughes, and K. S. Campbell
KIR2DL4 Differentially Signals Downstream Functions in Human NK Cells through Distinct Structural Modules
J. Immunol., March 1, 2008; 180(5): 2922 - 2932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Estefania, R. Flores, N. Gomez-Lozano, H. Aguilar, M. Lopez-Botet, and C. Vilches
Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets
J. Immunol., April 1, 2007; 178(7): 4402 - 4410.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs
Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells
J. Leukoc. Biol., December 1, 2006; 80(6): 1529 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. C. Viertlboeck, F. A. Habermann, R. Schmitt, M. A. M. Groenen, L. Du Pasquier, and T. W. Gobel
The Chicken Leukocyte Receptor Complex: A Highly Diverse Multigene Family Encoding at Least Six Structurally Distinct Receptor Types
J. Immunol., July 1, 2005; 175(1): 385 - 393.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. Abi-Rached and P. Parham
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues
J. Exp. Med., April 18, 2005; 201(8): 1319 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kikuchi-Maki, T. L. Catina, and K. S. Campbell
Cutting Edge: KIR2DL4 Transduces Signals into Human NK Cells through Association with the Fc Receptor {gamma} Protein
J. Immunol., April 1, 2005; 174(7): 3859 - 3863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Nikolaidis, I. Makalowska, D. Chalkia, W. Makalowski, J. Klein, and M. Nei
Origin and evolution of the chicken leukocyte receptor complex
PNAS, March 15, 2005; 102(11): 4057 - 4062.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Draghi, N. Yawata, M. Gleimer, M. Yawata, N. M. Valiante, and P. Parham
Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I
Blood, March 1, 2005; 105(5): 2028 - 2035.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. I. Bonaparte and E. Barker
Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules
Blood, October 1, 2004; 104(7): 2087 - 2094.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-i. Yusa, T. L. Catina, and K. S. Campbell
KIR2DL5 Can Inhibit Human NK Cell Activation Via Recruitment of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2)
J. Immunol., June 15, 2004; 172(12): 7385 - 7392.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar
2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells
J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Toyama-Sorimachi, Y. Tsujimura, M. Maruya, A. Onoda, T. Kubota, S. Koyasu, K. Inaba, and H. Karasuyama
Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture
PNAS, January 27, 2004; 101(4): 1016 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. S. Campbell, S.-i. Yusa, A. Kikuchi-Maki, and T. L. Catina
NKp44 Triggers NK Cell Activation through DAP12 Association That Is Not Influenced by a Putative Cytoplasmic Inhibitory Sequence
J. Immunol., January 15, 2004; 172(2): 899 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kikuchi-Maki, S.-i. Yusa, T. L. Catina, and K. S. Campbell
KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-{gamma} Production
J. Immunol., October 1, 2003; 171(7): 3415 - 3425.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Goodridge, C. S. Witt, F. T. Christiansen, and H. S. Warren
KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells
J. Immunol., August 15, 2003; 171(4): 1768 - 1774.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Li, B. A. Rabinovich, R. Hurren, J. Shannon, and R. G. Miller
Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B
Int. Immunol., March 1, 2003; 15(3): 411 - 416.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Watzl and E. O. Long
Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts
J. Exp. Med., January 6, 2003; 197(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. F. Barber and E. O. Long
Coexpression of CD58 or CD48 with Intercellular Adhesion Molecule 1 on Target Cells Enhances Adhesion of Resting NK Cells
J. Immunol., January 1, 2003; 170(1): 294 - 299.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Boyson, R. Erskine, M. C. Whitman, M. Chiu, J. M. Lau, L. A. Koopman, M. M. Valter, P. Angelisova, V. Horejsi, and J. L. Strominger
Disulfide bond-mediated dimerization of HLA-G on the cell surface
PNAS, December 10, 2002; 99(25): 16180 - 16185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.